Loading...

FITC anti-mouse I-A/I-E Antibody

Pricing & Availability
Clone
M5/114.15.2 (See other available formats)
Regulatory Status
RUO
Other Names
MHC class II
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
m5/114.15.2 FITC
C57BL/6 mouse splenocytes were stained with anti-mouse I-A/I-E (clone M5/114.15.2) FITC (solid line) or rat IgG2b, κ FITC isotype control (dashed line).
  • m5/114.15.2 FITC
    C57BL/6 mouse splenocytes were stained with anti-mouse I-A/I-E (clone M5/114.15.2) FITC (solid line) or rat IgG2b, κ FITC isotype control (dashed line).
See FITC spectral data
Cat # Size Price Quantity Check Availability Save
107605 50 µg 57€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
107606 500 µg 176€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

These class II molecules are expressed on antigen presenting cells (including B cells) and a subset of T cells from H-2b,d,q,r bearing mice and are involved in antigen presentation to T cells expressing CD3/TCR and CD4 proteins.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Activated C57BL/6 mouse spleen cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

The M5/114.15.2 antibody reacts with a polymorphic determinant shared by the I-Ab, I-Ad, I-Aq, I-Ed, and I-Ek MHC class II alloantigens from mice carrying H-2p,r,q,b,d,u haplotypes. Clone M5/114.15.2 however does not react wtih I-Af, I-Ak, or I-As MHC class II alloantigens.1

Additional reported applications (for the relevant formats) include: immunoprecipitation1, immunohistochemistry of frozen sections2,3,6, in vitro and in vivo blocking of antigen presentation or ligand binding4-7, and spatial biology (IBEX)17,18. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 107655 & 107656).

Application References

(PubMed link indicates BioLegend citation)
  1. Bhattacharya A, et al. 1981. J. Immunol. 127:2488. (IP)
  2. Viville S, et al. 1993. Cell 72:635. (IHC)
  3. Nelson AJ, et al. 1993. J. Immunol. 151:2453. (IHC)
  4. Shi Y, et al. 1998. J. Exp. Med. 187:367. (Block)
  5. Yamashita I, et al. 1993. Int. Immunol. 5:1139.
  6. Guo M, et al. 1995. Zygote 3:65. (IHC)
  7. Kim A, et al. 2004. Exp. Mol. Med. 36:428. (Block)
  8. Luckashenak NA, et al. 2006. J. Immunol. 177:5177.
  9. Venanzi ES, et al. 2007. J. Immunol. 179:5693.
  10. Christensen SR, et al. 2006. Immunity 25:417. PubMed
  11. Matte-Martone C, et al. 2008. Blood 111:3884. PubMed
  12. De Pascalis R, et al. 2008. Infect. Immun. 76:4311. PubMed
  13. Kuns RD, et al. 2009. Blood 113:5999. PubMed
  14. Sabatino JJ, et al. 2011. J. Exp. Med. 208:81. PubMed
  15. Draber P, et al. 2011. Mol Cell Biol. 22:4550. PubMed
  16. Fu H, et al. 2014. Nat Commun. 5:3436. PubMed
  17. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  18. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Wijayadikusumah A, et al. 2017. Amino Acids. 10.1007/s00726-017-2466-6. PubMed
  2. Donaldson B, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0270-1. PubMed
  3. Zhang J, et al. 2018. Sci Rep. 8:2373. PubMed
  4. Van Dis E, et al. 2018. Cell Rep. 23:1435. PubMed
  5. Hernández–Santos N, et al. 2018. Cell Host Microbe. 1.313194444. PubMed
  6. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  7. Zwick M, et al. 2019. Front Immunol. 10:222. PubMed
  8. Sultan H, et al. 2018. Cancer Immunol Res. 6:617. PubMed
  9. Hakim R, et al. 2019. Stem Cell Res Ther. 10:115. PubMed
  10. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  11. Wu J, et al. 2019. J Immunol Res. 2019:1749803. PubMed
  12. Kimura A, et al. 2018. J Exp Med. 215:2197. PubMed
  13. Danne C et al. 2017. Cell host & microbe. 22(6):733-745 . PubMed
  14. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  15. Wang H et al. 2017. Developmental cell. 40(6):566-582 . PubMed
  16. Mulder R, et al. 2017. Front Immunol. 1.464583333. PubMed
  17. Kramer K, et al. 2017. ACS Omega. 0.240972222. PubMed
  18. Orillion A, et al. 2018. Clin Cancer Res. 24:6383. PubMed
  19. Qu J, et al. 2018. J Immunol Res. 2018:7519856. PubMed
  20. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  21. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  22. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  23. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  24. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  25. Park CJ, et al. 2020. Cell Reports. 31(2):107496.. PubMed
  26. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  27. Tsukasaki M, et al. 2020. Cell Reports. 32(10):108124. PubMed
  28. Hays C, et al. 2020. eLife. 8:e48772.. PubMed
  29. Steinmann S, et al. 2020. Sci Rep. 1.160416667. PubMed
  30. He Y, et al. 2020. Sci Adv. 6:eaba7589. PubMed
  31. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  32. Morris E, et al. 2005. J Clin Invest. 115:3093. PubMed
  33. Kaplan D, et al. 2007. J Exp Med. 204:2545. PubMed
  34. Banovic T, et al. 2009. J Immunol. 182:912. PubMed
  35. Xiao S, Manley N 2010. PLoS One. 5:e15396. PubMed
  36. Dutta S, et al. 2012. Eukaryot Cell. 0.756944444. PubMed
  37. Dong S, et al. 2007. Int Immunopharmacol. 7:725. PubMed
  38. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  39. Steinbach K, et al. 2013. J Immunol. 191:4531. PubMed
  40. Koma T, et al. 2014. J Virol. 88:7178. PubMed
  41. Nakamura M, et al. 2015. J Immunol. 194:243. PubMed
  42. Reynolds A, et al. 2015. J Immunol. 194:231. PubMed
  43. White C, et al. 2015. J Immunol. 194:697. PubMed
  44. Stack G, et al. 2015. PLoS Pathog. 11:1004641. PubMed
  45. Harberts E, et al. 2015. J Immunol. 194:3127. PubMed
  46. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  47. Schulz A, et al. 2015. J Biol Chem. 211: 553 - 567. PubMed
  48. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  49. Spanier J, et al. 2016. Nat Commun. 7:11804. PubMed
  50. Miki Y, et al. 2016. J Biol Chem. 291: 15588 - 15601. PubMed
  51. Maisel D, et al. 2016. PLoS One. 11: 0159716. PubMed
  52. Hidaka T, et al. 2016. Nat Immunol. 18:64-73. PubMed
  53. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  54. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  55. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  56. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  57. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  58. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  59. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  60. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  61. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  62. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  63. Kim SH, et al. 2021. Cell Reports. 35(2):108995. PubMed
  64. Dewi IMW, et al. 2021. Cell Reports Medicine. 2(5):100289. PubMed
  65. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  66. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  67. Zhao L, et al. 2021. STAR Protocols. 2:100732. PubMed
  68. Ayasoufi K, et al. 2020. Brain. 3629:143. PubMed
  69. Dobosz E, et al. 2021. Dis Model Mech. :14. PubMed
  70. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  71. Al-Zaeed N, et al. 2021. Cell Death Dis. 12:611. PubMed
  72. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  73. Pierini S, et al. 2021. J Immunother Cancer. 9:. PubMed
  74. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  75. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  76. Hickey A, et al. 2021. Front Microbiol. 12:653587. PubMed
  77. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  78. Nicholls J, et al. 2021. Front Cell Dev Biol. 9:737880. PubMed
  79. Vorselen D, et al. 2021. Elife. 10:. PubMed
  80. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  81. Pradhan K, et al. 2021. Front Immunol. 12:778830. PubMed
  82. Budai Z, et al. 2021. Cells. 10:. PubMed
  83. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  84. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  85. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  86. Nguyen T, et al. 2021. STAR Protoc. 2:101004. PubMed
  87. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  88. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  89. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  90. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  91. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  92. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  93. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  94. Matsumura F, et al. 2021. J Immunol. 207:938. PubMed
  95. Deets KA, et al. 2021. Elife. 10:. PubMed
  96. Mainz RE, et al. 2022. Cells. 11:. PubMed
  97. Tarban N, et al. 2022. Cells. 11:. PubMed
  98. Ghorbani S, et al. 2022. Nat Commun. 13:2445. PubMed
  99. Grube J, et al. 2022. Cell Death Dis. 13:704. PubMed
  100. Sim SL, et al. 2022. Front Endocrinol (Lausanne). 13:957833. PubMed
  101. Renga G, et al. 2020. Life Sci Alliance. 3:. PubMed
  102. Kelly SH, et al. 2021. Adv Healthc Mater. 10:e2001614. PubMed
  103. Zou J, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:983. PubMed
  104. Luo M, et al. 2021. J Immunol. 207:1683. PubMed
  105. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  106. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  107. Kang SJ, et al. 2022. Food Sci Anim Resour. 42:903. PubMed
  108. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  109. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  110. Zhang P, et al. 2022. BMC Med. 20:435. PubMed
  111. Wang S, et al. 2022. Sci Adv. 8:eabn3883. PubMed
  112. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  113. Mugarza E, et al. 2022. Sci Adv. 8:eabm8780. PubMed
  114. Que W, et al. 2022. Sci Adv. 8:eabo4413. PubMed
  115. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  116. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  117. Drummer C, et al. 2023. Front Immunol. 14:1113883. PubMed
  118. Yang Z, et al. 2022. J Nucl Med. 63:1708. PubMed
  119. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  120. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  121. Sheng YH, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:789. PubMed
  122. Qiu Z, et al. 2022. J Exp Med. 219:. PubMed
  123. Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed
  124. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  125. Chen X, et al. 2023. Adv Mater. 35:e2210440. PubMed
  126. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  127. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  128. Guo Z, et al. 2023. Int J Mol Sci. 24:. PubMed
  129. Yao H, et al. 2023. Front Immunol. 14:1147674. PubMed
  130. Shen Z, et al. 2023. iScience. 26:106572. PubMed
  131. He Y, et al. 2023. Biomolecules. 13:. PubMed
  132. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  133. Yao RQ, et al. 2023. Mil Med Res. 10:27. PubMed
RRID
AB_313320 (BioLegend Cat. No. 107605)
AB_313321 (BioLegend Cat. No. 107606)

Antigen Details

Structure
MHC class II
Distribution

B cell and activated T cells, APCs of the H-2b,d,q,r bearing mice

Function
Antigen presentation
Ligand/Receptor
CD3/TCR, CD4
Cell Type
Antigen-presenting cells, B cells, Dendritic cells, T cells, Tregs
Biology Area
Immunology, Innate Immunity
Molecular Family
MHC Antigens
Antigen References

1. Watts C. 1997. Ann. Rev. Immunol. 15:821.
2. Pamer E, et al. 1998. Ann. Rev. Immunol. 16:323.

Gene ID
14961 View all products for this Gene ID 14969 View all products for this Gene ID
UniProt
View information about I-A/I-E on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 4    Revision Date: 10.30.2014

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account